Ad is loading...
MENU
MREO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mereo BioPharma Group (MREO) Ownership - Who owns Mereo BioPharma Group?
Profile
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
33
Web
https://www.mereobiopharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
547.66M
P/E Ratio
N/A
Total Cash
87.43M
Projected Growth
N/A
Total Debt
6.16M
Revenue
1M
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash/Share
0.56
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
MREO
Capitalization
548M
P/E Ratio
N/A
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash
87.4M
Total Cash/Share
0.56
Total Debt
6.16M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
1M
ROE
N/A
Book Value
78.6M
P/B Ratio
7.55
Cash Flow
N/A
Earnings
-0.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.03M
Current Ratio
6.07
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-34.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.25
Shares Held By Institutions
360M
Shares Outstanding - Current
155M
Total Liabilities
17.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
52.814
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
33
Web
https://www.mereobiopharma.com